DC airport ground stop: FAA issues update on Potomac TRACON; first details on ‘chemical smell’

Baltimore-Washington International Thurgood Marshall Airport is among the DC airports where a ground stop was issued by the ...

Flights delayed at BWI, DC airports due to "strong chemical smell" at air traffic control center

Three major airports in the Baltimore, DC region, including Baltimore Washington International Thurgood Marshall Airport (BWI), went under a ground stop Friday afternoon, affecting hundreds of flights ...

Flight delays: Overheating circuit board causes strong chemical smell at Potomac TRACON

The unexpected evacuation of Potomac TRACON due to a strong chemical smell left air traffic controllers and passengers in a ...
Nasdaq

TRACON Pharmaceuticals Announces Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab

SAN DIEGO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development ...
Nasdaq

TRACON Pharmaceuticals Announces Positive Results Based on Ongoing Double-Digit Objective Response Rate for Single Agent Envafolimab in the ENVASARC Phase 2 Pivotal Trial

SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform ...
Seeking Alpha

TRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to ...
Business Insider

TRACON Pharmaceuticals Announces Submission of IND Application for TJ4309 (CD73 Antibody TJD5) for Treatment of Advanced Solid Tumors

SAN DIEGO, Dec. 26, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...